Elenestinib
- Generic Name
- Elenestinib
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C27H29FN10O
- CAS Number
- 2505078-08-8
- Unique Ingredient Identifier
- 6FBM4CP6RK
- Background
Elenestinib is a selective KIT inhibitor.
- Associated Conditions
- -
- Associated Therapies
- -
Continued Leadership in Redefining the Standard of Care in Systemic Mastocytosis
ASH data show AYVAKIT® (avapritinib) improves survival in advanced systemic mastocytosis (SM) patients, with bone density improvements and undetected KIT mutations identified by ultra-sensitive testing. Blueprint Medicines presented these findings at the 66th ASH Annual Meeting.
Game-Changing Results in Systemic Mastocytosis Treatment
ASH data show AYVAKIT® (avapritinib) improves survival in advanced systemic mastocytosis (SM) patients, with bone density improvements and undetected KIT mutations identified by ultra-sensitive testing.
Blueprint Medicines' Continued Leadership in Redefining the Standard of Care in Systemic
ASH data show AYVAKIT® (avapritinib) improves survival in advanced systemic mastocytosis (SM) patients, with bone density improvements and undetected KIT mutations identified by ultra-sensitive testing. Blueprint Medicines' HARBOR trial aims to assess disease-modifying impact.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath